Physiomics plc combines systems biology, PKPD and cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the company’s lead service, is used to optimise the dosing and scheduling of oncology drugs in pre-clinical and clinical trials. This optimisation improves the efficacy of combinations and streamlines the drug development
…More process. The Company has worked in the small molecule as well as the biological space and has experience of traditional chemo, targeted chemo and immuno-therapies.